Filtering by:
Screening GuidelinesYear in Review: Cancer Research Insights from 2019
Overall, the US cancer death rate is continuing to decrease, but there’s more to that story. Throughout 2019, the recurring themes of cancer research news included the link between obesity and cancer, increased rates of certain cancers in people younger than 50, and continued barriers to cancer care due to poverty, race, where people live, and other factors. Here are 10 of the stories that made headlines in 2019 based on the work of American Cancer Society (ACS) staff and funded researchers.
Report Outlines the Future Potential of Cancer Screenings
Cancer screening has helped saved hundreds of thousands of lives. But “millions of people in the US who should be screened aren’t getting screened, and millions who are being screened aren’t receiving the highest quality testing available,” said Robert A. Smith, PhD. Narrowing these gaps could allow screening to save even more lives.
More Colorectal Cancer Diagnoses in People Under 55 Aren’t Only Because of More Colonoscopies
Colorectal cancer (CRC) is being diagnosed more often in the United States among adults younger than age 55. Does this mean more of them are getting colorectal cancer? Or are doctors finding it more often because more younger adults are having colonoscopies? In a study published in the Journal of Medical Screening, researchers at the American Cancer Society (ACS) found that colonoscopy trends don’t completely line up with the rates of colorectal cancer diagnosis by age, so more screening doesn’t fully explain the rise in CRC cases.
Study: Premature Deaths from Cancer in One Year Led to Loss of 8.7 Million Years of Life and $94 Billion of Future Earnings
Cancer kills many people before their time, costing more than 8.7 million years of life among people aged 16 to 84 in the United States in 2015. Researchers estimate cancer also leads to $94 billion in future lost earnings, not just in 2015. These numbers come from a new report by American Cancer Society (ACS) researchers in JAMA Oncology.